American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MarketAxess Holdings
MKTX
|
+$239M |
| 2 |
Eli Lilly
LLY
|
+$204M |
| 3 |
Duke Energy
DUK
|
+$179M |
| 4 |
Colgate-Palmolive
CL
|
+$178M |
| 5 |
Labcorp
LH
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$265M |
| 2 |
Emerson Electric
EMR
|
+$236M |
| 3 |
Quest Diagnostics
DGX
|
+$200M |
| 4 |
Aflac
AFL
|
+$139M |
| 5 |
ServiceNow
NOW
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.47% |
| 2 | Financials | 15.64% |
| 3 | Healthcare | 15.07% |
| 4 | Consumer Discretionary | 10.54% |
| 5 | Industrials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
F&G Annuities & Life
FG
$3.56B
| $201K | ﹤0.01% |
+10,021
| New | +$204K |
|
|
DCPH
2327
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $196K | ﹤0.01% |
+11,938
| New | +$194K |
|
2328
Resources Connection
RGP
$145M
| $196K | ﹤0.01% |
+10,638
| New | +$196K |
|
2329
Harrow
HROW
$1.49B
| $194K | ﹤0.01% |
+13,128
| New | +$157K |
|
|
RADI
2330
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $190K | ﹤0.01% |
16,060
+4,291
| +36% | +$44.5K |
|
2331
Crawford & Co Class A
CRD.A
$630M
| $183K | ﹤0.01% |
32,865
-5,362
| -14% | -$32.6K |
|
2332
Frontline
FRO
$9.05B
| $182K | ﹤0.01% |
15,019
| – | – |
|
2333
Viking Therapeutics
VKTX
$3.88B
| $182K | ﹤0.01% |
+19,345
| New | +$86.4K |
|
2334
Nature's Sunshine
NATR
$277M
| $180K | ﹤0.01% |
21,629
+673
| +3% | +$5.7K |
|
2335
Mission Produce
AVO
$1.15B
| $178K | ﹤0.01% |
+15,353
| New | +$236K |
|
2336
American Well
AMWL
$221M
| $178K | ﹤0.01% |
3,136
+1,058
| +51% | +$76.2K |
|
2337
Ginkgo Bioworks
DNA
$491M
| $176K | ﹤0.01% |
2,609
+1,246
| +91% | +$115K |
|
2338
Melco Resorts & Entertainment
MLCO
$2.15B
| $175K | ﹤0.01% |
15,178
+1,663
| +12% | +$13.5K |
|
2339
BioCryst Pharmaceuticals
BCRX
$2.52B
| $174K | ﹤0.01% |
+15,142
| New | +$189K |
|
2340
Lemonade
LMND
$4.02B
| $173K | ﹤0.01% |
+12,628
| New | +$250K |
|
|
SBT
2341
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $170K | ﹤0.01% |
27,986
| – | – |
|
|
API
2342
Agora
API
$400M
| $169K | ﹤0.01% |
+43,220
| New | +$143K |
|
2343
Select Water Solutions
WTTR
$2.68B
| $168K | ﹤0.01% |
18,229
+6,660
| +58% | +$56.1K |
|
2344
UiPath
PATH
$7.87B
| $168K | ﹤0.01% |
+13,180
| New | +$163K |
|
|
FRBK
2345
DELISTED
Republic First Bancorp Inc
FRBK
| $167K | ﹤0.01% |
77,794
+18,868
| +32% | +$50.1K |
|
|
TE
2346
T1 Energy
TE
$1.46B
| $167K | ﹤0.01% |
19,264
-130
| -0.7% | -$1.63K |
|
|
AUD
2347
DELISTED
Audacy, Inc.
AUD
| $166K | ﹤0.01% |
737,031
-9,387
| -1% | -$2.96K |
|
2348
WisdomTree
WT
$3.4B
| $161K | ﹤0.01% |
29,544
+9,153
| +45% | +$47.6K |
|
2349
Constellium
CSTM
$3.98B
| $161K | ﹤0.01% |
13,575
+76
| +0.6% | +$888 |
|
2350
Montauk Renewables
MNTK
$270M
| $158K | ﹤0.01% |
+14,309
| New | +$191K |
|
Similar funds
American Century Companies's Q4 2022 Portfolio in Review
As of Q4 2022, American Century Companies held 2,650 positions worth $122B, up 7.7% from $114B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
American Century Companies's Q4 2022 filing shows 220 new, 1,560 increased, 662 reduced and 73 closed positions. Its largest new stake was NextEra Energy, Inc. 6.926% Corporate Units: 903,403 shares worth $45.5M. The largest sale was Alphabet (Google) Class A, an estimated $265M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q4 2022 buy was NextEra Energy, Inc. 6.926% Corporate Units: 903,403 shares worth $45.5M.
- American Century Companies added most to MarketAxess Holdings in Q4 2022, an estimated $239M increase.
- American Century Companies's biggest Q4 2022 reduction was Alphabet (Google) Class A, cutting an estimated $265M.
- American Century Companies fully exited Abiomed Inc in Q4 2022, selling an estimated $96.8M.
- American Century Companies's ten largest holdings make up 19% of its $122B portfolio in Q4 2022.
- American Century Companies opened 220 new positions and closed 73 in Q4 2022.
- American Century Companies's portfolio value rose 7.7% quarter-over-quarter to $122B.
Based on American Century Companies's 13F filing for Q4 2022, filed 13 Feb 2023.